N/A
N=223
Epidemiology and Prevention of Methicillin Resistant Staphylococcus Aureus (MRSA) Transmission in the Community
MRSA - Methicillin Resistant Staphylococcus Aureus Infection
Bottom Line
View on ClinicalTrials.gov: NCT00966446 ↗Enrolled (actual)
223
Serious AEs
7.2%
Results posted
Jun 2016
Primary outcome: Primary: Recurrent Infection — 1; 3; 1 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Unsupervised Decolonization (Drug); Supervised Decolonization (Drug)
- Age
- Pediatric, Adult, Older Adult · 0+ yrs
- Sex
- All
- Sponsor
- University of Pennsylvania
- Primary completion
- Sep 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Recurrent Infection |
1; 3; 1 | — |
| PRIMARY First Two Consecutive Sampling Periods Completed |
48; 49; 52 | — |
| SECONDARY Time to Clearance of Methicillin-resistant Staphylococcus Aureus (MRSA) Colonization |
23; 23; 19 | — |
Summary
The overall goal of this project is to elucidate the epidemiology of MRSA transmission in the community and test an intervention to prevent MRSA transmission in this setting.
Eligibility Criteria
Inclusion Criteria
- All members of a household in which the index case is treated for a skin or soft tissue infection due to MRSA. All household members must agree to participate in order for the household to be enrolled
Exclusion Criteria
- Prior MRSA within past 6 months in the index case; age less than 6 months.
Data sourced from ClinicalTrials.gov (NCT00966446). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.